SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...
ZEISS Medical Technology, one of the world's leading medical technology companies, today launched its ZEISS Collaborative Care browser-based software application enabling eye care professionals to ...
The eye is a unique window to overall health. Its associated medical imaging has great characteristics, such as being non-invasive, convenient, and rich in information, which offers significant ...
Phase 3 Pivotal Trials Met Pre-Specified Primary Efficacy Endpoints for Both Doses of iDose TR (Fast- and Slow-Release Models), Supporting Anticipated Upcoming NDA Submission 93% of Slow-Release iDose ...
Glaukos Corporation (NYSE:GKOS), a leader in the ophthalmic medical technology industry with a market capitalization of $8.85 ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...
SHANGHAI, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Headquartered in Shanghai, Arctic Vision (Cayman) Limited (“Arctic Vision”), a global ophthalmic company, announced that it has entered into an agreement to ...
Over 11,000 Experts from 111 Countries Converge Reaffirming Hong Kong’s Position as a Global Ophthalmic Hub HONG KONG SAR - Media OutReach Newswire - 13 February 2026 - The four-day "APAO 2026 ...
HONG KONG SAR - Media OutReach Newswire - 13 February 2026 - The four-day "APAO 2026 Asia-Pacific Academy of Ophthalmology (APAO) Congress" successfully concluded last week, marking a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results